E. Ohman J:or Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-6,700
Closed -$170K – 443
2022
Q3
$170K Hold
6,700
– – 0.01% 416
2022
Q2
$223K Hold
6,700
– – 0.01% 409
2022
Q1
$483K Hold
6,700
– – 0.02% 379
2021
Q4
$615K Hold
6,700
– – 0.02% 382
2021
Q3
$850K Buy
6,700
+1,800
+37% +$262K 0.03% 322
2021
Q2
$815K Hold
4,900
– – 0.03% 324
2021
Q1
$891K Sell
4,900
-600
-11% -$139K 0.03% 285
2020
Q4
$1.1M Buy
5,500
+2,400
+77% +$488K 0.04% 220
2020
Q3
$680K Hold
3,100
– – 0.03% 227
2020
Q2
$592K Buy
+3,100
New +$543K 0.03% 229

Other funds holding TDOC

E. Ohman J:or Asset Management's TDOC Position: Q4 2022 in Review

E. Ohman J:or Asset Management sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 6,700 shares — an estimated $170K sold.

E. Ohman J:or Asset Management first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $1.1M in Q4 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • E. Ohman J:or Asset Management reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • E. Ohman J:or Asset Management sold 6,700 Teladoc Health shares in Q4 2022, an estimated $170K.
  • E. Ohman J:or Asset Management first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • E. Ohman J:or Asset Management's Teladoc Health position peaked at $1.1M in Q4 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on E. Ohman J:or Asset Management's 13F filing for Q4 2022, filed 5 Apr 2024.